candoxatrilat has been researched along with dx 9065 in 1 studies
Studies (candoxatrilat) | Trials (candoxatrilat) | Recent Studies (post-2010) (candoxatrilat) | Studies (dx 9065) | Trials (dx 9065) | Recent Studies (post-2010) (dx 9065) |
---|---|---|---|---|---|
46 | 10 | 1 | 17 | 0 | 0 |
Protein | Taxonomy | candoxatrilat (IC50) | dx 9065 (IC50) |
---|---|---|---|
Coagulation factor X | Oryctolagus cuniculus (rabbit) | 0.041 | |
Coagulation factor X | Homo sapiens (human) | 0.085 | |
Trypsin-1 | Homo sapiens (human) | 3.2 | |
Trypsin-2 | Homo sapiens (human) | 3.2 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.07 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.07 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.07 | |
Translocator protein | Homo sapiens (human) | 0.07 | |
Trypsin-3 | Homo sapiens (human) | 3.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbenante, G; Fairlie, DP; Leung, D | 1 |
1 review(s) available for candoxatrilat and dx 9065
Article | Year |
---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |